Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput ScreeningWei Zhu, Wei Zheng, Miao Xu et al.|ACS Pharmacology & Translational Science|2020Cited by 225
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped ParticlesCatherine Z. Chen, Gary R. Whittaker, Miao Xu et al.|ACS Pharmacology & Translational Science|2020Cited by 128
Synergistic and Antagonistic Drug Combinations against SARS-CoV-2Tesia Bobrowski, Eugene Muratov, Lu Chen et al.|Molecular Therapy|2020Cited by 127
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2Catherine Z. Chen, Wei Zheng, Paul Shinn et al.|Frontiers in Pharmacology|2021Cited by 95
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19Xin Hu, Min Shen, Jonathan H. Shrimp et al.|ACS Pharmacology & Translational Science|2021Cited by 56